These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 17881448)
21. Chimaeric VP2 proteins from infectious bursal disease virus containing the N-terminal M2e of H9 subtype avian influenza virus induce neutralizing antibody responses to both viruses. Tang Y; Gong Y; Wang Y; Wu P; Liu Y; Lu J; Gao F; Chen T; Hou F; Hou J Avian Pathol; 2013; 42(3):260-7. PubMed ID: 23607544 [TBL] [Abstract][Full Text] [Related]
22. Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States. Snyder DB; Vakharia VN; Savage PK Arch Virol; 1992; 127(1-4):89-101. PubMed ID: 1333761 [TBL] [Abstract][Full Text] [Related]
23. Real-time RT-PCR analysis of two epitope regions encoded by the VP2 gene of infectious bursal disease viruses. Mickael CS; Jackwood DJ J Virol Methods; 2005 Sep; 128(1-2):37-46. PubMed ID: 16023522 [TBL] [Abstract][Full Text] [Related]
24. Characterization of field and vaccine infectious bursal disease viruses from Nigeria revealing possible virulence and regional markers in the VP2 minor hydrophilic peaks. Adamu J; Owoade AA; Abdu PA; Kazeem HM; Fatihu MY Avian Pathol; 2013; 42(5):420-33. PubMed ID: 23919308 [TBL] [Abstract][Full Text] [Related]
25. A very virulent genotype of infectious bursal disease virus predominantly associated with recurrent infectious bursal disease outbreaks in Tunisian vaccinated flocks. Mardassi H; Khabouchi N; Ghram A; Namouchi A; Karboul A Avian Dis; 2004 Dec; 48(4):829-40. PubMed ID: 15666864 [TBL] [Abstract][Full Text] [Related]
26. Protection against infectious bursal disease virulent challenge conferred by a recombinant avian adeno-associated virus vaccine. Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Williams S Avian Dis; 2008 Jun; 52(2):315-9. PubMed ID: 18646463 [TBL] [Abstract][Full Text] [Related]
27. Effective protection by high efficiency bicistronic DNA vaccine against infectious bursal disease virus expressing VP2 protein and chicken IL-2. Kumar S; Ahi YS; Salunkhe SS; Koul M; Tiwari AK; Gupta PK; Rai A Vaccine; 2009 Feb; 27(6):864-9. PubMed ID: 19111591 [TBL] [Abstract][Full Text] [Related]
28. Antigenic structure analysis of VP3 of infectious bursal disease virus. Deng X; Gao Y; Gao H; Qi X; Cheng Y; Wang X; Wang X Virus Res; 2007 Oct; 129(1):35-42. PubMed ID: 17590471 [TBL] [Abstract][Full Text] [Related]
29. Development of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens. Rong J; Cheng T; Liu X; Jiang T; Gu H; Zou G Vaccine; 2005 Sep; 23(40):4844-51. PubMed ID: 15979770 [TBL] [Abstract][Full Text] [Related]
30. Modified activity of a VP2-located neutralizing epitope on various vaccine, pathogenic and hypervirulent strains of infectious bursal disease virus. Eterradossi N; Toquin D; Rivallan G; Guittet M Arch Virol; 1997; 142(2):255-70. PubMed ID: 9125042 [TBL] [Abstract][Full Text] [Related]
31. Mucosal application of cationic poly(D,L-lactide-co-glycolide) microparticles as carriers of DNA vaccine and adjuvants to protect chickens against infectious bursal disease. Negash T; Liman M; Rautenschlein S Vaccine; 2013 Aug; 31(36):3656-62. PubMed ID: 23777953 [TBL] [Abstract][Full Text] [Related]
32. Protection of chickens, with or without maternal antibodies, against IBDV infection by a recombinant IBDV-VP2 protein. Zhou X; Wang D; Xiong J; Zhang P; Li Y; She R Vaccine; 2010 May; 28(23):3990-6. PubMed ID: 20338216 [TBL] [Abstract][Full Text] [Related]
33. Sequence and phylogenetic analysis of the VP2 gene of very virulent infectious bursal disease virus isolates. Hoque MM; Omar AR; Hair-Bejo M; Aini I J Biochem Mol Biol Biophys; 2002 Apr; 6(2):93-9. PubMed ID: 12186763 [TBL] [Abstract][Full Text] [Related]
34. Characterization of infectious bursal disease viruses from four layer flocks in the United States. Sreedevi B; LeFever LJ; Sommer-Wagner SE; Jackwood DJ Avian Dis; 2007 Dec; 51(4):845-50. PubMed ID: 18251392 [TBL] [Abstract][Full Text] [Related]
35. Identification of neutralizing epitopes on the VP2 protein of infectious bursal disease virus by phage-displayed heptapeptide library screening and synthetic peptide mapping. Wang XN; Zhang GP; Zhou JY; Feng CH; Yang YY; Li QM; Guo JQ; Qiao HX; Xi J; Zhao D; Xing GX; Wang ZL; Wang SH; Xiao ZJ; Li XW; Deng RG Viral Immunol; 2005; 18(3):549-57. PubMed ID: 16212534 [TBL] [Abstract][Full Text] [Related]
36. Infectious bursal disease virus structural proteins expressed in a baculovirus recombinant confer protection in chickens. Vakharia VN; Snyder DB; He J; Edwards GH; Savage PK; Mengel-Whereat SA J Gen Virol; 1993 Jun; 74 ( Pt 6)():1201-6. PubMed ID: 8389805 [TBL] [Abstract][Full Text] [Related]
37. Anti-idiotypic antibody specific for an infectious bursal disease virus-neutralizing monoclonal antibody does not interfere with the virus infection. Yamaguchi T; Igusa A; Setiyono A; Fukushi H; Hirai K Arch Virol; 2002 Oct; 147(10):2017-23. PubMed ID: 12376762 [TBL] [Abstract][Full Text] [Related]
38. Amino acid comparison of infectious bursal disease viruses placed in the same or different molecular groups by RT/PCR-RFLP. Jackwood DJ; Sommer SE; Knoblich HV Avian Dis; 2001; 45(2):330-9. PubMed ID: 11417812 [TBL] [Abstract][Full Text] [Related]
39. The genetic basis for the antigenicity of the VP2 protein of the infectious bursal disease virus. Schnitzler D; Bernstein F; Müller H; Becht H J Gen Virol; 1993 Aug; 74 ( Pt 8)():1563-71. PubMed ID: 7688411 [TBL] [Abstract][Full Text] [Related]
40. Comparison of neutralizing antigens of recent isolates of infections bursal disease virus. Reddy SK; Silim A Arch Virol; 1991; 117(3-4):287-96. PubMed ID: 1850233 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]